Pages that link to "Q37688040"
Jump to navigation
Jump to search
The following pages link to Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice. (Q37688040):
Displaying 11 items.
- Current progress in understanding the molecular pathogenesis of burn scar contracture (Q33717061) (← links)
- Transforming growth factor-β1/Smad3-independent epithelial-mesenchymal transition in type I collagen glomerulopathy. (Q41633919) (← links)
- Renal fibrosis: Recent translational aspects. (Q47239851) (← links)
- Sphingosine Kinase-2 Deficiency Ameliorates Kidney Fibrosis by Up-Regulating Smad7 in a Mouse Model of Unilateral Ureteral Obstruction (Q47954201) (← links)
- PDGF in organ fibrosis. (Q49864895) (← links)
- Inhibition of microRNA-23b prevents polymicrobial sepsis-induced cardiac dysfunction by modulating TGIF1 and PTEN (Q88517566) (← links)
- Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation (Q90066593) (← links)
- In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β (Q90217353) (← links)
- Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation (Q92536790) (← links)
- Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis (Q104269351) (← links)
- SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure (Q104493788) (← links)